Medpace Holdings Inc (MEDP)
390.78
-8.42
(-2.11%)
USD |
NASDAQ |
May 10, 15:58
Medpace Holdings Cash from Investing (TTM): -22.60M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -22.60M |
| December 31, 2023 | -34.63M |
| September 30, 2023 | -35.85M |
| June 30, 2023 | -34.38M |
| March 31, 2023 | -37.04M |
| December 31, 2022 | -38.74M |
| September 30, 2022 | -38.64M |
| June 30, 2022 | -38.05M |
| March 31, 2022 | -32.92M |
| December 31, 2021 | -31.36M |
| September 30, 2021 | -29.98M |
| June 30, 2021 | -32.02M |
| March 31, 2021 | -35.34M |
| December 31, 2020 | -31.21M |
| September 30, 2020 | -29.21M |
| June 30, 2020 | -26.70M |
| March 31, 2020 | -20.82M |
| December 31, 2019 | -19.14M |
| Date | Value |
|---|---|
| September 30, 2019 | -17.63M |
| June 30, 2019 | -14.28M |
| March 31, 2019 | -16.89M |
| December 31, 2018 | -16.97M |
| September 30, 2018 | -16.14M |
| June 30, 2018 | -15.70M |
| March 31, 2018 | -11.81M |
| December 31, 2017 | -12.24M |
| September 30, 2017 | -14.52M |
| June 30, 2017 | -14.27M |
| March 31, 2017 | -14.36M |
| December 31, 2016 | -13.42M |
| September 30, 2016 | -9.532M |
| June 30, 2016 | -9.427M |
| March 31, 2016 | -9.171M |
| December 31, 2015 | -6.432M |
| September 30, 2015 | -5.487M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-38.74M
Minimum
Dec 2022
-14.28M
Maximum
Jun 2019
-30.03M
Average
-31.69M
Median
Cash from Investing (TTM) Benchmarks
| Charles River Laboratories International Inc | -563.16M |
| Avid Bioservices Inc | -51.17M |
| Iovance Biotherapeutics Inc | -155.24M |
| Renovaro Inc | -1.121M |
| Candel Therapeutics Inc | -0.28M |